A Novel Limb Cryocompression System for Prevention of Chemotherapy Induced Peripheral Neuropathy - Expansion Study

NARecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

November 11, 2022

Primary Completion Date

November 30, 2026

Study Completion Date

November 30, 2026

Conditions
Chemotherapy-induced Peripheral Neuropathy
Interventions
DEVICE

Paxman Limb Cryocompression System (PLCS)

"The study population will comprise of cancer patients scheduled to receive weekly paclitaxel chemotherapy for a maximum of 12 cycles.~Cryocompression will be applied during every cycle of chemotherapy for a duration of up to 4 hours. All chemotherapy patients will receive 30 minutes pre-infusion cooling and 30 minutes post-infusion cooling. Cryocompression for each cycle will not exceed 4 hours. Chemotherapy and concomitant limb cryocompression are performed for 12 cycles and may be continued further in consultation with the PI. Overall, limb cryocompression will be administered for no longer than four hours."

Trial Locations (2)

119074

RECRUITING

National University Hospital, Singapore

329563

NOT_YET_RECRUITING

Curie Oncology, Mount Elizabeth Novena Specialist Centre, Singapore

All Listed Sponsors
collaborator

Paxman Coolers Ltd.

UNKNOWN

collaborator

The N.1 Institute for Health, National University of Singapore

UNKNOWN

collaborator

Curie Oncology, Mount Elizabeth Novena Specialist Centre

UNKNOWN

lead

National University Hospital, Singapore

OTHER

NCT05606068 - A Novel Limb Cryocompression System for Prevention of Chemotherapy Induced Peripheral Neuropathy - Expansion Study | Biotech Hunter | Biotech Hunter